Liz Parrish, founder of BioViva Sciences discusses the objective improvements in her biomarkers after taking gene therapy for telomerase and follastatin.
No Responses
Reading Time: < 1 minute
Liz Parrish and 2yr follow-up from telomerase gene therapy

Dr. Ed Park intervewed Liz Parrish, founder of BioViva Sciences at the the 2017 RAADFest. She discusses the objective improvements in her biomarkers after taking gene therapy for telomerase and follastatin.

Leave a Comment

Your email address will not be published. Required fields are marked *

How can I help you?

Drop me a line to find out

Contact Us

DISCLAIMER: This website is for educational purposes only and is not for advertising.  Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.

Facebook-f Twitter Youtube

Navigation

Subscribe to Dr. Park's weekly newsletter

Required fields

© 2020 Recharge Biomedical

Exosomes and TA-65 are not FDA-approved to prevent or treat any illness